THALLOUS CHLORIDE TI-201 INJECTION
Google image searchProduct monograph
Active ingredient
thallium chloride(ti 201), 37 MBq/ML
DIN: 02328925
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Schedule C
Company: CURIUM CANADA INC
Date: 09-DEC-2019
ATC:
- V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V09G — CARDIOVASCULAR SYSTEM (ATC, ATC/DDD)
- V09GX — Other cardiovascular system diagnostic radiopharmaceuticals (ATC, ATC/DDD)
- V09GX01 — THALLIUM 201 TL CHLORIDE (ATC/DDD)
